Loading clinical trials...
Loading clinical trials...
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Conditions
Interventions
intravitreal ranibizumab 0.3 mg
dexamethasone intravitreal implant
+1 more
Locations
56
United States
Retina-Vitreous Associates Medical Group
Beverly Hills, California, United States
Atlantis Eye Care
Huntington Beach, California, United States
Loma Linda University Health Care, Dept. of Ophthalmology
Loma Linda, California, United States
Northern California Retina Vitreous Associates
Mountain View, California, United States
Retina Consultants of Southern California
Redlands, California, United States
Retinal Consultants Medical Group, Inc.
Sacramento, California, United States
Start Date
February 1, 2014
Primary Completion Date
June 5, 2017
Completion Date
June 5, 2017
Last Updated
September 25, 2018
NCT07449936
NCT07449923
NCT07228559
NCT05802329
NCT06781255
NCT06701721
Lead Sponsor
Jaeb Center for Health Research
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions